Estimating survival in patients with cancer receiving palliative care: Is analysis of body composition using bioimpedance helpful?

Journal of Palliative Medicine

Volumn 12, Issue 11, 2009, Pages 1009-1014

  Crawford, Gregory Brian ^a   Robinson, Julie Ann ^b   Hunt, Roger Wayne ^a   Piller, Neil Brenton ^c   Esterman, Adrian ^d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BASAL METABOLIC RATE; BIOIMPEDANCE SPECTROSCOPY; BODY COMPOSITION; BODY FAT; BODY FLUID; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; EXTRACELLULAR FLUID; FEMALE; HUMAN; INTRACELLULAR FLUID; MAJOR CLINICAL STUDY; PROGNOSIS; SPECTROSCOPY; SURVIVAL RATE; SURVIVAL TIME;

AGED; AUSTRALIA; BASAL METABOLISM; BODY COMPOSITION; ELECTRIC IMPEDANCE; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; SPECTRUM ANALYSIS; SURVIVAL ANALYSIS; TERMINAL CARE;

EID: 70450183076     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2009.0093     Document Type: Article

References (45)

1. Wijnia JW, Corstiaensen IJ: A poor prognosis: Guide or misleading? Am J Hosp Palliat Med 2008;25:5-8.
2. Glare PA, Sinclair CT, Downing M, Stone P, Maltoni M, Vigano A: Predicting survival in patients with advanced disease. Eur J Cancer 2008;44:1146-1156.
3. Higginson IJ, Costantini M: Accuracy of prognosis estimates by four palliative care teams: A prospective cohort study. BMC Palliat Care 2002;1:1-5.
4. Christakis N, Lamont EB: Extent and determinants of error in doctors' prognoses in terminally ill patients: Prospective cohort study. BMJ 2000;320:469-473.
5. Llobera J, Esteva M, Rifà J, Benito E, Terrasa J, Rojas C, Pons O, Catalán G, Avellà A: Terminal cancer: Duration and prediction of survival time. Eur J Cancer 2000;36:2036-2043.
6. Twomey F, O'Leary N, O'Brien T: Prediction of patient survival by healthcare professionals in a specialist palliative care inpatient unit: A prospective study. Am J Hosp Palliat Med 2008;25:139-145.
7. Vigano A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME: Survival prediction in terminal cancer patients: A systematic review of the medical literature. Palliat Med 2000;14:363-374.
8. Chertow G, Jacobs D, Lazarus J, Lew N, Lowrie E: Phase angle predicts survival in hemodialysis patients. J Ren Nutr 1997;7:204-207.
9. Di Iorio B, Bellizzi V: Association of mortality and morbidity with bioimpedance analysis. Kidney Int 2000;58:464.
10. Di Iorio B, Terracciano V, Querques M, Ammirati G, De Franceso G, Lopez T: Bioimpedance indexes predict survival in hemodialysis patients. J Ren Nutr 1997;7:216-217.
11. Gupta D, Lammersfeld CA, Burrows JL, Dahlk SL, Vashi PG, Grutsch JF, Hoffman S, Lis CG: Bioelectrical impedance phase angle in clinical practice: Implications for prognosis in advanced colorectal cancer. Am J Clin Nutr 2004;80:1634-1638. (Pubitemid 41103864)
12. Gupta D, Lis CG, Dahlk SL, King J, Vashi PG, Grutsch JF, Lammersfeld CA: The relationship between bioelectrical impedance phase angle and subjective global assessment in advanced colorectal cancer. Nutr J 2008;7:19-25.
13. Gupta D, Lis CG, Dahlk SL, Vashi PG, Grutsch JF, Lammersfeld CA: Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr 2004;92:957-962.
14. Selberg O, Selberg D: Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol 2002;86:509-516.
15. Cornish B: Bioimpedance analysis: Scientific background. Lymph Res Biol 2006;4:47-50.
16. Toso S, Piccoli A, Gusella M, Menon D, Bononi A, Crepaldi G, Ferrazzi E: Altered tissue electric properties in lung cancer patients as detected by bioelectric impedance vector analysis. Nutrition 2000;16:120-124.
17. Toso S, Piccoli A, Gusella M, Menon D, Crepaldi G, Bononi A, Ferrazzi E: Bioimpedance vector pattern in cancer patients without disease versus locally advanced or disseminated disease. Nutrition 2003;19:510-514.
18. Ward LC: Bioelectrical Impedance Analysis: Proven utility in lymphedema risk assessment and therapeutic monitoring. Lymph Res Biol 2006;4:51-56.
19. Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Viganò A, Larkin P, De Conno F, Hanks G, Kaasa S; Steering Committee of the European Association for Palliative Care: Prognostic factors in advanced cancer patients: Evidence-based clinical recommendations-A study by the steering committee of the European Association for Palliative Care. J Clin Oncol 2005;23:6240-6248.
20. Cheung WY, Barmala N, Zarinehbaf S, Rodin G, Le LW, Zimmermann C: The association of physical and psychological symptom burden with time to death among palliative cancer outpatients. J Pain Symptom Manage 2009;37: 297-304.
21. Palmer JL, Fisch MJ: Association between symptom distress and survival in outpatients seen in a palliative care cancer center. J Pain Symptom Manage 2005;29:565-571.
22. Vigano A, Bruera E, Jhangri GS, Newmann SC, Fields AL, Suarez-Almazor ME: Clinical survival predictors in patients with advanced cancer. Arch Intern Med 2000;160:861-868. (Pubitemid 30165248)
23. Chuang R-B, Hu W-Y, Chiu T-Y, Chen C-Y: Prediction of survival in terminal cancer patients in Taiwan: Constructing a prognostic scale. J Pain Symptom Manage 2004;28:115-122.
24. Morita T, Tsunoda J, Inoue S, Chihara S: The Palliative Prognostic Index: A scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer 1999;7: 128-133.
25. Stone P, Kelly L, Head R, White S: Development and validation of a prognostic scale for use in patients with advanced cancer. Palliat Med 2008;22:711-717.
26. Hartsell WF, Desilvio M, Buner DW, Scarantino C, Ivker R, Roach M 3rd, Suh J, Demas WF, Movsas B, Petersen IA, Konski AA: Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 97-14. J Palliat Med 2008;11:723-727.
27. Glare PA, Eychmueller S, McMahon P: Diagnostic accuracy of the Palliative Prognostic Score in hospitalized patients with advanced cancer. J Clin Oncol 2004;22:4823-4828.
28. Head B, Ritchie CS, Smoot TM: Prognostication in hospice care: Can the Palliative Performance Scale help? J Palliat Med 2005;8:492-502.
29. Morita T, Tsunoda J, Inoue S, Chihara S: Improved accuracy of physicians' survival prediction for terminally ill cancer patients using the Palliative Prognostic Index. Palliat Med 2001;15:419-424.
30. Stone CA, Tiernan E, Dooley BA: Prospective validation of the Palliative Prognostic Index in patients with cancer. J Pain Symptom Manage 2008;35:617-622.
31. Stone PC, Lund S: Predicting prognosis in patients with advanced cancer. Ann Oncol 2007;18:971-976.
32. Maturo G, Vespasiani G, Mohamed E, Maiolo C, Finazzi Agrò E, Forte F, De Lorenzo A: Evaluating body composition of Italian prostate cancer patients without metastases. Acta Diabetol 2003;40:S168-S170.
33. Calling S, Hedblad B, Engström G, Berglund G, Janzon L: Effects of body fatness and physical activity on cardiovascular risk: Risk prediction using the bioelectrical impedance method. Scand J Public Health 2006;34:568-575.
34. Palmieri V, Roman MJ, Bella JN, Liu JE, Best LG, Lee ET, Howard BV, Devereux RB: Prognostic implications of relations of left ventricular systolic dysfunction with body composition and myocardial energy expenditure: The Strong Heart Study. J Am Soc Echocardiogr 2008;21:66-71.
35. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF: Body composition and mortality in Chronic Obstructive Pulmonary Disease. Am J Clin Nutr 2005;82:53-59.
36. Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sørensen TI, Lange P: Body mass, fat-free body mass, and prognosis in patients with Chronic Obstructive Pulmonary Disease from a random population sample: Findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006;173:79-83.
37. Beddhu S, Pappas LM, Ramkumar N, Samore M: Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003;14:2366-2372.
38. Bosaeus I, Daneryd P, Lundholm K: Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. J Nutr 2002;132:3465S-3466.
39. Tajika M, Kato M, Mohri H, Miwa Y, Kato T, Ohnishi H, Moriwaki H: Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 2002;18:229-234.
40. Slinde F, Grönberg A, Engström C-P, Rossander-Hulthén L, Larsson S: Body composition by bioelectrical impedance predicts mortality in chronic obstructive pulmonary disease patients. Respir Med 2005;99:1004-1009. (Pubitemid 40796543)
41. Cha K, Shin S, Shon C, Choi S, Wilmore DW: Evaluation of segmental bioelectrical impedance analysis (SBIA) for measuring muscle distribution. J Int Council Health Phys Educ Recreation Sport Dance 1997;(Spring):11-14.
42. Chumlea W, Guo S, Cockram D, Siervogel R: Mechanical and physiologic modifiers and bioelectrical impedance spectrum determinants of body composition. Am J Clin Nutr 1996;64:413S-422S.
43. Cornish B, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, Thomas BJ: Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 2001;34:2-11.
44. Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, Lis CG: Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer 2008;8: 249-255.
45. Faris M: Clinical estimation of survival and impact of other prognostic factors on terminally ill cancer patients in Oman. Support Care Cancer 2003;11:30-34